Abstract | OBJECTIVE: Our goal in this study aims to explain the polypharmacological mechanism at the molecular level responsible for the effectiveness of a traditional Chinese medicine (TCM) prescription FTZ to treat hyperlipidemia and related disease. DESIGN: By MDL(®) ISIS_Base 2.5, we constructed a compound database based on the FTZ constituents, which were detected in the rat serum after oral administration of the TCM through ultra-performance liquid chromatography/quadruple-time-of-flight mass-spectrometry (UPLC/Q-TOF-MS/MS) method. After validation of the virtual docking system, we used molecular screening by LigandFit which is a computational method for the shape-directed rapid docking of ligands to target protein active sites, to investigate the interactions between the components in database and lipid-modulating targets in the liver. RESULTS: CONCLUSIONS:
|
Authors | Laiyou Wang, Weiye Tao, Duosheng Luo, Yinming Hu, Weijian Bei, Jiao Guo |
Journal | Complementary therapies in medicine
(Complement Ther Med)
Vol. 22
Issue 5
Pg. 887-93
(Oct 2014)
ISSN: 1873-6963 [Electronic] Scotland |
PMID | 25440380
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Copyright | Copyright © 2014 Elsevier Ltd. All rights reserved. |
Chemical References |
- Drugs, Chinese Herbal
- FTZ formula
- Lipid Regulating Agents
- Lipids
|
Topics |
- Animals
- Drug Synergism
- Drugs, Chinese Herbal
(pharmacokinetics, pharmacology)
- Lipid Metabolism
(drug effects)
- Lipid Regulating Agents
(blood, pharmacokinetics, pharmacology)
- Lipids
(blood)
- Liver
(drug effects, metabolism)
- Metabolic Networks and Pathways
- Molecular Docking Simulation
- Rats
|